MedPath

Phase II study of efficiency of peripheral blood stem cell harvest in POEMS syndrome patients with low-dose cyclophosphamide plus G-CSF

Phase 2
Conditions
POEMS syndrome
Registration Number
JPRN-UMIN000018385
Lead Sponsor
Chiba University Hospital Department of Hematology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
14
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with plasma cells in CBC 2) Pregnant or nursing women. Patients reuse to contraception during examination period 3) Patients have active other malignant diseases including simultaneous cancer and disease free state within 5 years after treatment for other cancer except curable intramural cancer by local treatment. 4) Patients with serious mental disorders 5) Patients with HBs antigen-positive 6) Patients with HIV antibody-positive 7) Patients with a history of severe allergy to the drugs 8) Patients with serious active infection 9) Patients who are determined to be inappropriate for this study by physicians

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patients collecting >= 2*10^6 CD34+ cells/kg on day 1 (%)
Secondary Outcome Measures
NameTimeMethod
Safety Effect of this regimen on engraftment Incidence of adverse events (Grade 3) The day of first apheresis
© Copyright 2025. All Rights Reserved by MedPath